or
forgot password

    • cancer clinical trials in tennessee

    • Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Non-small Cell Lung Cancer (NSCLC)
    Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
    Vanderbilt Children's Hospital
    Nashville, Tennessee 37232-6310
    Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Disorders, Acute Lymphocytic Leukemia, Acute Promyelocytic Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia, Myelofibrosis, Chronic Myelomonocytic Leukemia, Juvenile Myelomonocytic Leukemia
    NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer
    Center for Biomedical Research - Oncology
    Knoxville, Tennessee 37909
    Colorectal Cancer
    S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
    Erlanger Cancer Center at Erlanger Hospital - Baroness

    Trial Locations
    Erlanger Cancer Center at Erlanger Hospital - Baroness
    Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center
    Breast Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Erlanger Medical Center

    Trial Locations
    Erlanger Medical Center
    Thompson Cancer Survival Center
    Meharry Medical College
    Nashville Oncology Associates PC
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
    University of Tennessee Cancer Institute

    Trial Locations
    University of Tennessee Cancer Institute
    Accelerated Community Oncology Reseaerch Network, Inc. (ACORN)
    Peripheral T-cell Lymphoma
    Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer
    Tennessee Oncology
    Nashville, Tennessee 37203
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
    T.C. Thompson Children's Hospital

    Trial Locations
    T.C. Thompson Children's Hospital
    St. Jude Children's Research Hospital
    Leukemia
    A Feasibility Study of SAHA Combined With Isotretinoin and Chemotherapy in Infants With Embryonal Tumors of the Central Nervous System
    St. Jude Children's Research Hospital

    Trial Locations
    St. Jude Children's Research Hospital
    Pediatric Brain Tumor Consortium
    Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    T.C. Thompson Children's Hospital

    Trial Locations
    T.C. Thompson Children's Hospital
    East Tennessee Children's Hospital
    Vanderbilt-Ingram Cancer Center
    Leukemia, Lymphoma
    Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab
    MBCCOP - Meharry Medical College - Nashville

    Trial Locations
    MBCCOP - Meharry Medical College - Nashville
    Vanderbilt Heart One Hundred Oaks
    Breast Cancer, Cardiac Toxicity, Cardiovascular Complications
    Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Unknown Primary Cancer
    Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Brain Cancer, Pediatric Cancers
    A Study of Carfilzomib Maintenance Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Multiple Myeloma
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Erlanger Medical Center

    Trial Locations
    Erlanger Medical Center
    Jackson-Madison County General Hospital
    Thompson Cancer Survival Center
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
    SCRI Chattanooga Oncol & Hematol Assoc, PC - Chattanooga

    Trial Locations
    SCRI Chattanooga Oncol & Hematol Assoc, PC - Chattanooga
    SCRI Tennessee Oncology - PLLC Franklin
    SCRI Tennessee Oncology- Gallatin
    SCRI Tennessee Oncology, PLLC Hermitage
    SCRI Chattanooga Oncol & Hematol Assoc, PC Hixson
    CCOP Holston Valley Medical Center
    SCRI Tennessee Oncology Lebanon
    SCRI Tennessee Oncology Murfreesboro
    Tennessee Oncology
    SCRI Tennessee Oncology, PLLC (Harding)
    SCRI - Tennessee Oncology PLLC
    SCRI Tennessee Onclogy, PLLC (Dickerson)
    SCRI Tennessee Oncology, PLLC (Wallace)
    SCRI Tennessee Oncology, PLLC Smyrna
    Breast Cancer
    Trial of Poor Performance Status Patients (ToPPS)
    Chattanooga Oncology Hematology Associates

    Trial Locations
    Chattanooga Oncology Hematology Associates
    Tennessee Oncology, PLLC
    Family Cancer Center
    Non Small Cell Lung Cancer
    Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
    Tennessee Oncology
    Nashville, Tennessee 37203
    Metastatic Breast Cancer
    Study of Proteins in Head and Neck Cancer Cells
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Vanderbilt-Ingram Cancer Center at Franklin
    Head and Neck Cancer